Physician profile
John T Lake
NPI 1629270194
$1,790.82
in general payments reported to CMS, 2019-2025
11 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $468 · 2021: $567 · 2022: $75.96 · 2023: $218 · 2024: $126 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $499.14 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $403.63 | 2019-2024 | Spravato |
| Allergan, INC. | $327.72 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $164.30 | 2019-2025 | Rexulti, Abilify Maintena |
| Axsome Therapeutics, INC. | $111.39 | 2023-2025 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $82.48 | 2022-2024 | Caplyta |
| Lundbeck LLC | $69.88 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $66.66 | 2023-2024 | Ingrezza |
| Phathom Pharmaceuticals, INC. | $25.01 | 2025 | Voquezna |
| Inspire Medical Systems, INC. | $23.12 | 2023 | Inspire |
| Eisai INC. | $17.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.